Microglia‐Targeted Biomimetic Tetrahedral Framework Nucleic Acid Nanovesicles for Synergistic Treatment of Sepsis‐Associated Encephalopathy
Advanced Science · 2026-07 · 13 (40)
DOI: 10.1002/advs.202523716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.04.2026. Verfasst von Huimin Shi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shenzhen Clinical College (Longgang Central Hospital of Shenzhen), Guangzhou University of Chinese Medicine, Shenzhen, …. Hauptthemen laut MEDLINE: Microglia, Sepsis-Associated Encephalopathy, Nucleic Acids, Biomimetic Materials. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Program.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐associated encephalopathy (SAE), the most prevalent and severe complication of sepsis, is a leading cause of long‐term cognitive deficits and increased mortality. Although anti‐inflammatory and antioxidant therapies have advanced, single‐target drugs cannot disrupt the complex inflammatory cascade in SAE. Therefore, multi‐target synergistic strategies are urgently needed. This study developed a multifunctional biomimetic nanodrug, ME@FDsi, for precise SAE therapy. The system uses a tetrahedral framework nucleic acid (tFNA) as a carrier, connected via base complementary pairing with small interfering RNA (siTNFα) to target TNF‐α. It is also loaded with disulfiram (DSF) to inhibit pyroptosis. The resulting FDsi was encapsulated in erythrocyte membrane vesicles modified with the M1 microglia‐targeting MG1 peptide. ME@FDsi exhibits a nanovesicle structure, prolonged circulation, stability, and biocompatibility. In SAE mice, it crosses the compromised blood‐brain barrier and targets M1 microglia via MG1, releasing DSF and siTNF‐α intracellularly. DSF blocks pyroptosis and IL‐1β release, while siTNFα silences TNF‐α expression. Additionally, tFNA scavenges reactive oxygen species. Together, these actions shift microglia from the M1 to the M2 phenotype. ME@FDsi treatment improved cognitive function, reduced multi‐organ damage, and increased survival in SAE mice. This multi‐mechanism synergistic approach offers a promising therapeutic strategy for clinical SAE and sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shenzhen Clinical College (Longgang Central Hospital of Shenzhen), Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
- Institute for Engineering Medicine, Kunming Medical University, Kunming, Yunnan, China.
- School of Inspection, Ningxia Medical University, Yinchuan, Ningxia, China.
- Department of Anesthesiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- Institute for Engineering Medicine, NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan, China.
- Geriatric Medical Center, Division of Geriatric Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Yuhui Liao
Förderung
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Program
- National Natural Science Foundation of China
- Key Research and Development Program of Ningxia Hui Autonomous Region
- Natural Science Foundation of Ningxia-Outstanding Youth Program
- Innovative Team of Yunnan Province
Zitieren
APA
Shi, H., Gao, Q., Wang, W., Li, B., Chen, Y., Yao, Z., Li, Y., Li, J., Li, N., Gu, G., Hou, Z., Yang, M., Zhang, R., Yang, H., Liao, Y., & Lei, H. (2026). Microglia‐Targeted Biomimetic Tetrahedral Framework Nucleic Acid Nanovesicles for Synergistic Treatment of Sepsis‐Associated Encephalopathy. Advanced Science, 13(40). https://doi.org/10.1002/advs.202523716
Vancouver
Shi H, Gao Q, Wang W, Li B, Chen Y, Yao Z, et al. Microglia‐Targeted Biomimetic Tetrahedral Framework Nucleic Acid Nanovesicles for Synergistic Treatment of Sepsis‐Associated Encephalopathy. Advanced Science. 2026;13(40). doi:10.1002/advs.202523716
BibTeX
@article{Shi2026,
author = {Shi, Huimin and Gao, Qiuxia and Wang, Wenying and Li, Bin and Chen, Yukun and Yao, Zhijun and Li, Yujie and Li, Junrui and Li, Na and Gu, Gong and Hou, Zhimin and Yang, Mengyuan and Zhang, Ruilin and Yang, Hongju and Liao, Yuhui and Lei, Hongyi},
title = {Microglia‐Targeted Biomimetic Tetrahedral Framework Nucleic Acid Nanovesicles for Synergistic Treatment of Sepsis‐Associated Encephalopathy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {40},
doi = {10.1002/advs.202523716}
}
EUVIMED